Health & Biotech ‘Miracle’ breakthrough in melanoma fight puts focus on ASX stocks in the skin cancer space June 11, 2021 One person in Australia is told they have melanoma every 30 minutes. These are the ASX stocks looking for breakthroughs… Check Up: As Alzheimer’s grabs the spotlight, these ASX biotech stocks also impressed June 10, 2021 Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent… New breakthrough in stem cells research paves the way for ASX regenerative medicine stocks June 9, 2021 A recent article published in the Advance Science magazine discussed research by Monash University that uncovered a new technique to… Intelicare flags major traction from recent marketing drive as brand awareness rises sharply June 8, 2021 Special Report: The company has leveraged data insights to refocus its targeted marketing campaigns for high-growth channels. Health Kick: New ASX listee Audeara uses algorithms to create perfect audio and better hearing health June 8, 2021 Audeara is a hearing health technology company that has developed a hearing profile algorithm used to personalise sound output to… Creso Pharma’s takeover target expands scope of PTSD ‘shroom’ trial beyond military vets June 8, 2021 Special Report: Creso Pharma's takeover target will broaden the scope of its upcoming clinical trial evaluating “magic mushrooms” as a… FDA’s landmark approval of Biogen’s Alzheimer’s drug sends Cogstate up 60 per cent June 8, 2021 Cogstate (ASX:CGS) has become the latest ASX health stock to gain from an FDA green light even though it is… Executive insights: How Apiam is capitalising on the major opportunity in ‘greenfield’ vet clinics June 7, 2021 Special Report: Apiam’s two brand new clinics in regional Victoria are already delivering on early growth expectations. Dimerix secures ILAP approval in the UK as it builds momentum with global health regulators June 7, 2021 Special Report: Fast-track approval for DMX-200 in the UK follows a similar ruling in Europe last week. Creso Pharma sells hemp products in Ecuador, gears up for the lucrative Latin American market June 7, 2021 Special Report: The extended deal signed by Creso Pharma will see the company enter Ecuador for the first time, as… Next» « Previous